Literature DB >> 11243409

The Drosophila TATA binding protein contains a strong but masked activation domain.

M Um1, J L Manley.   

Abstract

TATA binding protein (TBP) is a critical transcription factor involved in transcription by all three RNA polymerases (RNAPs). Studies using in vitro systems and yeast have shown that the C-terminal core domain (CTD) of TBP is necessary and sufficient for many TBP functions, but the significance of the N-terminal domain (NTD) of TBP is still obscure. Here, using transient expression assays in Drosophila Schneider cells, we show that the NTD of Drosophila TBP (dTBP) strongly activates transcription when fused to the GAL4 DNA binding domain (DBD). Strikingly, the activity of the NTD is completely repressed in the context of full-length dTBP. In contrast to the much weaker activation obtained by either full-length dTBP or the dTBP CTD fused to the GAL4 DBD, activation by the NTD is dependent on the presence of GAL4 binding sites and is susceptible to the effects of a dominant negative TFIIB mutant, TFIIB deltaC202, a property observed previously with certain authentic activation domains. Activation by the NTD, but not full-length dTBP or the CTD, seems to be mediated by the action of a strong activation domain, likely a glutamine-rich region. In conclusion, the dTBP NTD can behave as a very strong activator that is masked in the full-length protein, suggesting possible roles for the dTBP NTD in RNAP II-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11243409      PMCID: PMC5964934          DOI: 10.3727/000000001783992669

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  30 in total

1.  Dominant negative mutations in yeast TFIID define a bipartite DNA-binding region.

Authors:  P Reddy; S Hahn
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

2.  cDNA clone encoding Drosophila transcription factor TFIID.

Authors:  M L Muhich; C T Iida; M Horikoshi; R G Roeder; C S Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Analysis of polyglutamine-coding repeats in the TATA-binding protein in different human populations and in patients with schizophrenia and bipolar affective disorder.

Authors:  D C Rubinsztein; J Leggo; T J Crow; L E DeLisi; C Walsh; S Jain; E S Paykel
Journal:  Am J Med Genet       Date:  1996-09-20

Review 4.  TBP, a universal eukaryotic transcription factor?

Authors:  N Hernandez
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

5.  Factors (TAFs) required for activated transcription interact with TATA box-binding protein conserved core domain.

Authors:  Q Zhou; T G Boyer; A J Berk
Journal:  Genes Dev       Date:  1993-02       Impact factor: 11.361

6.  Stimulation of RNA polymerase II transcription initiation by recruitment of TBP in vivo.

Authors:  N Klages; M Strubin
Journal:  Nature       Date:  1995-04-27       Impact factor: 49.962

7.  Striking homology of the 'variable' N-terminal as well as the 'conserved core' domains of the mouse and human TATA-factors (TFIID).

Authors:  T Tamura; K Sumita; I Fujino; A Aoyama; M Horikoshi; A Hoffmann; R G Roeder; M Muramatsu; K Mikoshiba
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

8.  C-terminal domain (CTD) of RNA-polymerase II and N-terminal segment of the human TATA binding protein (TBP) can mediate remote and proximal transcriptional activation, respectively.

Authors:  K Seipel; O Georgiev; H P Gerber; W Schaffner
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

9.  Crystal structure of a TFIIB-TBP-TATA-element ternary complex.

Authors:  D B Nikolov; H Chen; E D Halay; A A Usheva; K Hisatake; D K Lee; R G Roeder; S K Burley
Journal:  Nature       Date:  1995-09-14       Impact factor: 49.962

10.  Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.

Authors:  M K Perez; H L Paulson; S J Pendse; S J Saionz; N M Bonini; R N Pittman
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.